Condo Pharmacy

Proud and grateful to be Plattsburgh’s longest serving community pharmacy! @NY_Pharmacists, @Compliantrx93, @Commpharmacy, @a4pcrx, and @CPESN member. #FixRx

[Antonio Ciaccia @A_Ciaccia]

“It’s a shell game …

Money was diverted from Medicaid to the PBM that should have gone to patient prescription delivery.”

@RobSandIA @iastateauditor @pharmalot https://t.co/GLopppq4kl

[NCPA @Commpharmacy]

🚀 Ready to move beyond enrollment and workflow? Join our advanced ACCESS to Pharmacy Care webinar on July 21 at 8 p.m. ET to learn the clinical "how-tos" of delivering services within the program.

We'll cover patient identification, clinical interventions, documentation best practices, care plan development, and real-world implementation strategies to help you confidently integrate ACCESS to Pharmacy Care into your practice.

🔗 Register now: https://t.co/5g3ywIYoAk
Learn more about ACCESS: https://t.co/0WM7rd5umV

[Ted Okon @TedOkonCOA]

JUST OUT -- Our Perspective in @JCOOP_ASCO on the new @ASCO policy position on #340B. 340B discounts should go to patients in need, not wealthy hospital systems. Congress never intended hospitals, and now corporate #PBMs, from profiting off of 340B.
https://t.co/p4PWKmGJaS

[NCPA @Commpharmacy]

👏👏👏 Congratulations to Louisiana pharmacists and @LIPAPharmacy for the recent signing of Act 913!

This bill establishes a NADAC + reimbursement floor for commercial reimbursement. It also requires PBMs to reprocess all claims between January 1 and June 12, 2026, with the $9.00 dispensing fee per the Department of Insurance’s existing standard. Most importantly, this will help preserve patient access to local, accessible, and personalized healthcare!

🔗 To learn more: https://t.co/Rr5PA7jOUB

[Antonio Ciaccia @A_Ciaccia]

“This lack of transparency is obviously a massive red flag …

We believe that Iowans deserve to know how their tax dollars are being spent.” - @iastateauditor @RobSandIA

[Antonio Ciaccia @A_Ciaccia]

“Oh, we got rid of PBM spread pricing years ago”

I can’t tell you how many times I’ve heard this phrase, but I can tell you that almost every time, it’s wrong.

Thanks @iastateauditor for working with us to bring transparency & accountability to Medicaid

https://t.co/m83J7YffHt

[Steve Moore @SteveMooreRx]

@NYS_AM what is going on with A5882c? 121/150 members have signed on as cosponsors, it deserves a vote!

Don’t let PCMA stop you from protecting patient access to pharmacy care in communities across New York.

#FixRx

[Steve Moore @SteveMooreRx]

Big thank you to Senate Sponsor @JamesSkoufis for taking on PBM profiteering in the commercial market!

[Mark Cuban @mcuban]

https://t.co/ZOf0wjM4Sb

[NCPA @Commpharmacy]

🙌 “...I plan on signing it.” says Tennessee’s @GovBillLee when asked about the landmark FAIR Rx Act.

To learn more about the bill and @TNPharm‘s fight to get it across the finish line, watch our latest podcast episode with @pudlo!

📺 https://t.co/NwOS1vygvm

[NCPA @Commpharmacy]

🏠 Ready to operationalize Pharmacy Care at Home, but not sure where to start?

Join our Learning Hour webinar on May 21 at 2 p.m. ET for a breakdown of how to navigate CMS LTC requirements, identify eligible patients, and unlock sustainable reimbursement with the right billing strategies.

🔗 Register now: https://t.co/luwzzER1Mj

[NCPA @Commpharmacy]

🚨 Attention, Kentucky pharmacists!

Former Kentucky Attorney General Daniel Cameron, a candidate in the U.S. Senate race, is hosting a press conference in Bowling Green to talk PBM reform. Get to know where Cameron stands on the issues that impact you and your patients before the election.

When: Tuesday, April 14 at 9 a.m. CT

Where: CDS #10 Pharmacy

More info: https://t.co/eiBZo3Zg12

@KyPharmAssoc

[Clinton County HD @ClintonCountyHD]

Babies receive short-term protection from passive immunity (mother to baby), but it doesn't activate their immune system. They have no memory cells or antibodies against disease. Talk to your provider about when they recommend your child receive each of these important vaccines.

[Drug Channels @DrugChannels]

New IQVIA data shows how PBMs steer specialty prescriptions to their own pharmacies.

For patients starting a new brand-name drug:
• Oral oncology: 84% approval at PBM-affiliated pharmacies vs. 70% at unaffiliated pharmacies
• Autoimmune: 63% vs. 61%

But the pathway matters:
• First-fill approvals are far higher at PBM-affiliated pharmacies (42% vs. 14% in oncology; 29% vs. 8% in autoimmune)
• At unaffiliated pharmacies, many patients only get approved after switching (14% oncology; 20% autoimmune)

The result: PBM-owned pharmacies capture a disproportionate share of specialty volume.

Full report: https://t.co/EWauwCgOO2

[NCPA @Commpharmacy]

🎬 Ditch the mail order, there's a better experience waiting for you at a local community pharmacy — your pharmacy!

NCPA members, we're excited to showcase another commercial from our newly launched multi-million-dollar, multi-year advertising campaign. We’ll use digital media advertising to reach people within a three-mile radius of your pharmacy and drive them to your store through NCPA’s pharmacy locator.

Also, take advantage of this membership benefit to get customized ads for your pharmacy!

🔗 Learn more about this member benefit: https://t.co/Jj8GcnC5HD
P.S. Not a member yet? Join today to access this exclusive benefit: https://t.co/j6p32zow5e

[EPIC Rx @EPICRx]

EPIC Pharmacies buying group members earned $2.3M in our year-end dividend distribution! Compliant members earned free membership to EPN & PharmCAP, saving $3,600 annually! Learn more how our members saved in 2025 & how we can help you save this year. https://t.co/0cfYlmupTf

[Small Business Rising @RisingSmallBiz]

RSVP: @ilsr spotlights how pricing algorithms deployed by powerful corporations — including Amazon, Instacart, and major landlords — are inflating prices, undermining competition, and threatening small businesses and communities. https://t.co/ZxG85CsM8c

[NCPA @Commpharmacy]

🤝 Today we're unveiling the NCPA State Panel of Experts, a new program for state pharmacy associations that offers complimentary access to the country's best policy and legal minds to help with advancing pharmacy and patient-friendly policies. “Whether they’re fighting to change the pharmacy payment model and abusive PBM practices, pushing to advance pharmacists’ ability to practice at the top of their license, or serving the interests of their members in any other way, state pharmacy associations across the country do remarkable work, especially considering the limited resources and bandwidth they may have,” said NCPA CEO B. Douglas Hoey in announcing the program. “In addition to our federal and regulatory efforts, NCPA has also historically invested in state efforts to support independent pharmacy. We’re pleased to be adding this more formalized, free tool to support the work of our state colleagues.”

Learn more: https://t.co/TqIv2SnUBD

[Ted Okon @TedOkonCOA]

#340B hospitals will do anything to keep the 340B cash machine pumping drug profits that cost Americans billions. They don't want to provide data on drug costs to them because will show how much they profit from drugs.

https://t.co/DDb6EFPn2s

[Antonio Ciaccia @A_Ciaccia]

We're up to 761 brand drug list price increases and 18 decreases.

Refreshed data at @46brooklyndata: https://t.co/T05VaZieKQ